Effect of simvastatin on acute coronary syndrome complicated with atrial fibrillation
Ying Zhang
Abstract
Ying Zhang
Abstract
Objective: To investigate the effect of simvastatin on acute coronary syndrome complicated with atrial fibrillation.Methods: A total of 112 cases with acute coronary syndrome complicated with atrial fibrillation were randomly divided into treatment group(60 cases) and control group(52 cases).Besides conventional treatment,simvastatin was used at 40 mg/d for 4 weeks,then 20 mg/d.Therapy of simvastatin was irregular in control group with total course less than 8 weeks,and the total course was 12 months.Hepal and renal function,high senstive C-reaction protein,blood lipid,reoccurrence of paroxysmal atrial fibrillation,incidence of sustained or permanent atrial fibrillation and status of cardiovascular diseases.Results: There was insignificant difference in blood lipid and C-reactive protein before and after treatment in control group(P0.05).After treatment,the levels of total cholesterol,low-density cholesterol and C-reactive protein were significantly decreased(P0.05),and high-density lipoprotein was significantly increased(P0.05) in treatment group.6 cases(10%) had reoccurrence of paroxysmal atri-al fibrillation or had paroxysmal transforming into sustained or permanent one in treatment group,which was significantly lower than control group(17/52,36.5%)(P0.05).And 8 cases had cardiovascular problem,significantly lower than control group(22/52,42.3%)(P0.05).Conclusion: Simvastatin can regulate blood lipid,anti-atrial fibrillation,and decrease the incidence of cardiovascular diseases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of simvastatin on acute coronary syndrome complicated with atrial fibrillation.Methods: A total of 112 cases with acute coronary syndrome complicated with atrial fibrillation were randomly divided into treatment group(60 cases) and control group(52 cases).Besides conventional treatment,simvastatin was used at 40 mg/d for 4 weeks,then 20 mg/d.Therapy of simvastatin was irregular in control group with total course less than 8 weeks,and the total course was 12 months.Hepal and renal function,high senstive C-reaction protein,blood lipid,reoccurrence of paroxysmal atrial fibrillation,incidence of sustained or permanent atrial fibrillation and status of cardiovascular diseases.Results: There was insignificant difference in blood lipid and C-reactive protein before and after treatment in control group(P0.05).After treatment,the levels of total cholesterol,low-density cholesterol and C-reactive protein were significantly decreased(P0.05),and high-density lipoprotein was significantly increased(P0.05) in treatment group.6 cases(10%) had reoccurrence of paroxysmal atri-al fibrillation or had paroxysmal transforming into sustained or permanent one in treatment group,which was significantly lower than control group(17/52,36.5%)(P0.05).And 8 cases had cardiovascular problem,significantly lower than control group(22/52,42.3%)(P0.05).Conclusion: Simvastatin can regulate blood lipid,anti-atrial fibrillation,and decrease the incidence of cardiovascular diseases.
Key concepts: Simvastatin, Medicine, Atrial fibrillation, Internal medicine, Cardiology, Incidence (geometry), Acute coronary syndrome, Blood lipids